Novartis receives FDA approval for Signifor LAR to treat acromegaly

Swiss drugmaker Novartis has received approval from US Food and Drug Administration (FDA) for its Signifor long-acting release LAR (pasireotide) for injectable suspension and intramuscular use to treat patients with acromegaly.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news

Related Links:

Abstract Individuals with acromegaloid physical appearance or tall stature may be referred to endocrinologists to exclude growth hormone (GH) excess. While some of these subjects could be healthy individuals with normal variants of growth or physical traits, others will have acromegaly or pituitary gigantism, which are, in general, straightforward diagnoses upon assessment of the GH/IGF-1 axis. However, some patients with physical features resembling acromegaly - usually affecting the face and extremities -, or gigantism - accelerated growth/tall stature - will have no abnormalities in the GH axis. This scenario i...
Source: Frontiers in Neuroendocrinology - Category: Endocrinology Authors: Tags: Front Neuroendocrinol Source Type: research
Abstract Carney complex is a rare, autosomal dominant, multiple endocrine neoplasia and lentiginosis syndrome, caused in most patients by defects in the PRKAR1A gene, which encodes the regulatory subunit type 1α of protein kinase A. Inactivating defects of PRKAR1A lead to aberrant cyclic-AMP-protein kinase A signaling. Patients may develop multiple skin abnormalities and a variety of endocrine and non-endocrine tumors. Endocrine manifestations include primary pigmented nodular adrenocortical disease, that may cause Cushing syndrome, growth-hormone secreting pituitary adenoma or pituitary somatotropic hyperpl...
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Tags: Exp Clin Endocrinol Diabetes Source Type: research
Exp Clin Endocrinol Diabetes DOI: 10.1055/a-0753-4943Carney complex is a rare, autosomal dominant, multiple endocrine neoplasia and lentiginosis syndrome, caused in most patients by defects in the PRKAR1A gene, which encodes the regulatory subunit type 1α of protein kinase A. Inactivating defects of PRKAR1A lead to aberrant cyclic-AMP-protein kinase A signaling. Patients may develop multiple skin abnormalities and a variety of endocrine and non-endocrine tumors. Endocrine manifestations include primary pigmented nodular adrenocortical disease, that may cause Cushing syndrome, growth-hormone secreting pituitary adenom...
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Tags: Review Source Type: research
AbstractPurposeTo investigate the nodular thyroid disease (NTD) and the natural course of thyroid nodules in patients with acromegaly.Methods138 patients with acromegaly (73  F/65 M), whose initial thyroid ultrasonography performed in our university hospital, were included in this study. The frequencies of NTD, papillary thyroid cancer (PTC) and associated factors on nodule formation were investigated at initial assessment. Patients who had NTD continued to follow-up (n = 56) were re-evaluated with a ultrasonography performed after a mean 7-years follow-up period. The nodule size changes were compar...
Source: Pituitary - Category: Endocrinology Source Type: research
Publication date: Available online 10 November 2018Source: Advances in Virus ResearchAuthor(s): Eugene V. Koonin, Natalya YutinAbstractThe Nucleocytoplasmic Large DNA Viruses (NCLDV) of eukaryotes (proposed order “Megavirales”) comprise an expansive group of eukaryotic viruses that consists of the families Poxviridae, Asfarviridae, Iridoviridae, Ascoviridae, Phycodnaviridae, Marseilleviridae, Pithoviridae, and Mimiviridae, as well as Pandoraviruses, Molliviruses, and Faustoviruses that so far remain unaccounted by the official virus taxonomy. All these viruses have double-stranded DNA genomes that range in size...
Source: Advances in Virus Research - Category: Virology Source Type: research
In this study, we compared the GH nadir during OGTT in patients evaluated for acromegaly in the presence and absence of AGM.MethodsThis is a retrospective cohort study of patients with acromegaly (G1,n = 40) and a group in whom acromegaly was not confirmed (G2,n = 53) who had OGTT-GH suppression test during 2000–2012, using a monoclonal GH immunoenzymatic assay. The patients were categorized as having normal glucose metabolism (NGM) or AGM. GH nadir during OGTT in each group were compared.ResultsIn G1 and G2, 17 and 19 patients had AGM, respectively. Among 17 patients with diabetes, median...
Source: Endocrine - Category: Endocrinology Source Type: research
ConclusionTreatments used to normalize IGF-I levels in patients with acromegaly could have differential effects on cardiovascular risk factors and metabolic parameters.
Source: Endocrine - Category: Endocrinology Source Type: research
Abstract Ca2+ influx through voltage-gated Ca2+ channels (VGCCs) plays a key role in the secretion of growth hormone (GH). In this review, we summarize the current state of knowledge regarding the physiology and molecular machinery of VGCCs in pituitary somatotrophs. We next discuss the possible involvement of Ca2+ channelopathies in pituitary disease and the potential usage of Ca2+ channel blockers in the treatment of pituitary disease. Various types of VGCCs exist in pituitary cells. However, since L-type Ca2+ channels (LTCCs) contribute the major component to Ca2+ influx in somatotrophs, lactotrophs and cortico...
Source: Endocrinology - Category: Endocrinology Authors: Tags: Endocrinology Source Type: research
Authors: Katsumata N Abstract Determination of serum levels of GH and IGF-I is crucial for the diagnosis and treatment of GH deficiency and disorders related to GH excess such as acromegaly and pituitary gigantism. However, significant discrepancies in measured GH values among the methods were observed around the world. In Japan, the Study Committee for GH and Its Related Factors of The Foundation for Growth Science standardized GH values measured with various commercially available GH assay kits by creating formulas to adjust them to their averages. The committee also established reference values for IGF-I in Japa...
Source: Pediatric Endocrinology Reviews - Category: Endocrinology Tags: Pediatr Endocrinol Rev Source Type: research
Prof Márta Korbonits gave the Lady Estelle Wolfson lecture in translational medicine at the Royal College of Physicians on the 24 October 2018, during the Acute and General Medicine Conference. The lectureship is awarded to applicants who have made a contribution to translational research or medicine that has demonstrable benefit to patients.Prof Korbonits was selected for her translational work on conditions associated with growth hormone excess, starting in childhood and producing pituitary gigantism, and her talk was entitled,“Legends, genetics and molecular biology”.
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Acromegaly | Food and Drug Administration (FDA) | Pharmaceuticals